Orange Book product · Brand (NDA)

SAVELLA

MILNACIPRAN HYDROCHLORIDE

Brand (NDA)NDA 022256TE ABRX ABBVIE

Jan 14, 2009

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Jan 14, 2009
17 yr 8 mo ago
Today
Patent 7994220 expires
Listed method-of-use patent (U-819) expiration.
Sep 19, 2029
in 3 yr 4 mo

Active ingredient

MILNACIPRAN HYDROCHLORIDE

Strength

12.5MG

Dosage form

TABLET

Route

ORAL

TE code

Application

NDA 022256

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
7994220	Sep 19, 2029	in 3 yr 4 mo	U-819